These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24243925)

  • 1. Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials.
    Robson J; Doll H; Suppiah R; Flossmann O; Harper L; Höglund P; Jayne D; Mahr A; Westman K; Luqmani R
    Ann Rheum Dis; 2015 Jan; 74(1):177-84. PubMed ID: 24243925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials.
    Robson J; Doll H; Suppiah R; Flossmann O; Harper L; Höglund P; Jayne D; Mahr A; Westman K; Luqmani R
    Rheumatology (Oxford); 2015 Mar; 54(3):471-81. PubMed ID: 25205825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.
    Suppiah R; Hadden RD; Batra R; Arden NK; Collins MP; Guillevin L; Jayne DR; Luqmani RA;
    Rheumatology (Oxford); 2011 Dec; 50(12):2214-22. PubMed ID: 21890618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
    Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
    PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial.
    Hiemstra TF; Walsh M; Mahr A; Savage CO; de Groot K; Harper L; Hauser T; Neumann I; Tesar V; Wissing KM; Pagnoux C; Schmitt W; Jayne DR;
    JAMA; 2010 Dec; 304(21):2381-8. PubMed ID: 21060104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease and treatment-related morbidity in young and elderly patients with granulomatosis with polyangiitis and microscopic polyangiitis.
    Berti A; Felicetti M; Monti S; Ortolan A; Padoan R; Brunori G; Bortolotti R; Caporali R; Montecucco C; Schiavon F; Paolazzi G
    Semin Arthritis Rheum; 2020 Dec; 50(6):1441-1448. PubMed ID: 32173060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
    Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ
    Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data.
    de Joode AAE; Sanders JSF; Puéchal X; Guillevin LP; Hiemstra TF; Flossmann O; Rasmussen N; Westman K; Jayne DR; Stegeman CA
    Rheumatology (Oxford); 2017 Nov; 56(11):1894-1901. PubMed ID: 28977502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of renal involvement on survival in ANCA-associated vasculitis.
    Rathi M; Pinto B; Dhooria A; Sagar V; Mittal T; Rajan R; Dhir V; Kumar S; Sharma K; Nada R; Singh S; Minz RW; Sharma A
    Int Urol Nephrol; 2016 Sep; 48(9):1477-82. PubMed ID: 27272254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis.
    Sánchez Álamo B; Moi L; Bajema I; Faurschou M; Flossmann O; Hauser T; Hruskova Z; Jayne D; Luqmani R; Mahr A; Åkesson A; Westman K;
    Nephrol Dial Transplant; 2023 Jun; 38(7):1655-1665. PubMed ID: 36617233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome and treatment of elderly patients with ANCA-associated vasculitis.
    Weiner M; Goh SM; Mohammad AJ; Hruskova Z; Tanna A; Bruchfeld A; Selga D; Chocova Z; Westman K; Eriksson P; Pusey CD; Tesar V; Salama AD; Segelmark M
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1128-35. PubMed ID: 26100457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials.
    Heijl C; Harper L; Flossmann O; Stücker I; Scott DG; Watts RA; Höglund P; Westman K; Mahr A;
    Ann Rheum Dis; 2011 Aug; 70(8):1415-21. PubMed ID: 21616914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term patient survival in ANCA-associated vasculitis.
    Flossmann O; Berden A; de Groot K; Hagen C; Harper L; Heijl C; Höglund P; Jayne D; Luqmani R; Mahr A; Mukhtyar C; Pusey C; Rasmussen N; Stegeman C; Walsh M; Westman K;
    Ann Rheum Dis; 2011 Mar; 70(3):488-94. PubMed ID: 21109517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood.
    Calatroni M; Consonni F; Allinovi M; Bettiol A; Jawa N; Fiasella S; Curi D; Abu Rumeileh S; Tomei L; Fortunato L; Gelain E; Gianfreda D; Oliva E; Jeannin G; Salviani C; Emmi G; Bodria M; Sinico RA; Moroni G; Ramirez GA; Bozzolo E; Tombetti E; Monti S; Bracaglia C; Marucci G; Pastore S; Esposito P; Catanoso MG; Crapella B; Montini G; Roperto R; Materassi M; Rossi GM; Badalamenti S; Yeung RSM; Romagnani P; Ghiggeri GM; Noone D; Vaglio A
    Clin J Am Soc Nephrol; 2021 Jul; 16(7):1043-1051. PubMed ID: 34039568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroids in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Keller SF; Miloslavsky EM
    Rheum Dis Clin North Am; 2016 Feb; 42(1):91-101, viii. PubMed ID: 26611553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term damage assessment in patients with microscopic polyangiitis and renal-limited vasculitis using the Vasculitis Damage Index.
    Itabashi M; Takei T; Moriyama T; Shiohira S; Shimizu A; Tsuruta Y; Uchida K; Nitta K
    Mod Rheumatol; 2014 Jan; 24(1):112-9. PubMed ID: 24261767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-neutrophil cytoplasmic antibody-associated vasculitis. Clinical aspects and treatment].
    Paolini MV; Ruffino JP; Fernández Romero DS
    Medicina (B Aires); 2013; 73(2):119-26. PubMed ID: 23570759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series.
    Monti S; Montecucco C; Pieropan S; Mojoli F; Braschi A; Caporali R
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-126-31. PubMed ID: 26016763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
    Seo P; Min YI; Holbrook JT; Hoffman GS; Merkel PA; Spiera R; Davis JC; Ytterberg SR; St Clair EW; McCune WJ; Specks U; Allen NB; Luqmani RA; Stone JH;
    Arthritis Rheum; 2005 Jul; 52(7):2168-78. PubMed ID: 15986348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.